- Home
- OPHC vs XBIT Comparison
OPHC vs XBIT Comparison
Compare OPHC & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OPHC | XBIT |
|---|---|---|
| Founded | 2000 | 2005 |
| Country | United States | United States |
| Employees | N/A | 88 |
| Industry | Major Banks | Pharmaceuticals and Biotechnology |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.8M | 71.3M |
| IPO Year | 2012 | 2015 |
Fundamental Metrics
Financial Performance| Metric | OPHC | XBIT |
|---|---|---|
| Price | $5.42 | $2.31 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 33.5K | 24.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.71 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $17,095.98 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.75 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.76 | $2.09 |
| 52 Week High | $5.59 | $3.62 |
Technical Indicators
Market Signals| Indicator | OPHC | XBIT |
|---|---|---|
| Relative Strength Index (RSI) | 56.57 | 45.90 |
| Support Level | $4.00 | $2.32 |
| Resistance Level | $5.54 | $2.69 |
| Average True Range (ATR) | 0.15 | 0.10 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 77.61 | 43.10 |
Price Performance
Historical ComparisonAbout OPHC OptimumBank Holdings Inc.
OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides community banking services to individuals and corporate customers. Its services include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal accounts, money market deposit accounts, debit cards, and automated teller machines.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.